Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3192 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2927 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TOPISONE | 0.05% | LOTION | Resolved | 2024-05-09 | 2024-06-29 | 227462 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2024-06-07 | 2024-10-17 | 229939 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2024-07-04 | 2024-11-14 | 232198 |
| TEVA-TOPISONE | 0.05% | OINTMENT | Resolved | 2024-12-19 | 2025-03-13 | 246098 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2025-09-18 | 2025-11-20 | 267448 |
| TEVA-TOPOTECAN | 4MG | POWDER FOR SOLUTION | Resolved | 2022-05-19 | 2025-04-29 | 160980 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2019-10-24 | 2020-09-03 | 97150 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 325MG 37.5MG | TABLET | Resolved | 2021-02-25 | 2021-06-03 | 134738 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 325MG 37.5MG | TABLET | Resolved | 2021-03-18 | 2021-03-25 | 135955 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2022-04-21 | 2022-08-19 | 159213 |
| TEVA-TRAMADOL/ACETAMINOPHEN | 37.5MG 325MG | TABLET | Resolved | 2023-02-02 | 2023-06-09 | 183407 |
| TEVA-TRANDOLAPRIL | 0.5MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108003 |
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108006 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108009 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108012 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Resolved | 2017-03-13 | 2020-01-21 | 1659 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Resolved | 2017-03-13 | 2020-01-21 | 1664 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2018-03-13 | 2018-07-30 | 42576 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2018-03-13 | 2018-07-30 | 42579 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2019-10-31 | 2019-11-08 | 97599 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258501 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID FOR INJECTION | 4MG | SOLUTION | Discontinued | 2025-05-28 | 2025-05-28 | 258583 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |